Sunshine Biopharma (SBFM) vs XORTX Therapeutics (XRTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
XORTX Therapeutics is the larger company by market cap ($3.2 million vs $1.6 million), about 1.9 times the size. On valuation, Sunshine Biopharma trades at a lower forward P/E (0.0x vs 2.2x for XORTX Therapeutics).
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | SBFM | XRTX |
|---|---|---|
| Share price | $0.3814 | $1.75 |
| Market cap | $1.64M | $3.18M |
| 1-day change | -45.50% | +0.29% |
| Forward P/E | 0.00 | 2.18 |
| EPS (TTM) | $-9.45 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.30 | $7.05 |
| 52-week low | $0.356 | $1.59 |
| Distance from 52-week high | -98.43% | -75.18% |
| Average volume | 3.33M | 225.78K |
| Shares outstanding | 4.31M | 1.82M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
SBFM vs XRTX FAQ
Which is bigger, Sunshine Biopharma or XORTX Therapeutics?
XORTX Therapeutics (XRTX) is larger, with a market capitalization of $3.18M compared with $1.64M for Sunshine Biopharma (SBFM).
Are Sunshine Biopharma and XORTX Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.